Leaders like J.P. Morgan’s Jamie Dimon, acting Food and Drug Administration Commissioner Ned Sharpless, and researcher and author Dr. Siddhartha Mukherjee may be the marquee names at the biotech industry’s annual conference, BIO.
But increasingly, the convention program, which starts this week in Philadelphia, is putting a spotlight on smaller companies, too.
About the Author Reprints
